An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Our partner Prof Emanuele Neri from the University of Pisa (UNIPI) participated at the AIRMM/ISMRM ITALIAN CHAPTER Congress (Associazione Italiana di RM in Medicina / International Society of MR in Medicine) in Pisa (23-25/11/2022). Prof. Neri made a talk entitled “MRI in biobanks” during the “MR in oncology” session, where he discussed some issued also arised by ProCAncer-I project. The event was both in person and virtual, with participation from all over the world.
The ProCAncer-I project aims to revolutionize prostate cancer diagnosis and treatment through the power of artificial intelligence and advanced imaging. By creating a large, federated database of prostate MRI scans and clinical data, the project enables the...
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...
ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I project has aimed to establish a robust, ethically compliant AI platform—ProstateNet—to revolutionize prostate cancer (PCa) care through...
In the following AI-generated audio file, ProCAncer-I achievements are described in a simple way. Since its inception, the ProCAncer-I project has been on a mission to transform prostate cancer (PCa) care through advanced AI and ethically compliant data platforms. At...